Skip to main
University-wide Navigation

UK Research News

Side-by-side microscopic images compare brain tissue from a control sample and a PLX3397-treated sample. Fluorescent colors identify amyloid plaques, immune cells, and other cellular markers used to examine changes associated with Alzheimer’s disease.

Two hours of sleep restored: UK researchers make Alzheimer’s breakthrough

Jul 16, 2026, 9:35 AM

UK researchers have restored up to two hours of natural sleep in Alzheimer’s disease models, revealing a promising new pathway for treatment.

Linda Van Eldik, director of the UK Sanders-Brown Center on Aging, stands in a research laboratory.

Sanders-Brown director Linda Van Eldik honored with international lifetime achievement award for Alzheimer’s research

Jul 13, 2026, 7:11 AM

Internationally recognized Alzheimer’s disease expert Linda Van Eldik has received one of the field’s highest honors, the Khalid Iqbal Lifetime Achievement Award in Alzheimer’s Disease Research.

A woman looks at displayed scientific posters during a conference

Sanders-Brown researchers to share during Alzheimer’s Association International Conference

Jul 9, 2026, 7:45 AM

Several UK Sanders-Brown Center on Aging researchers will present their work during the Alzheimer’s Association International Conference in London from July 12-15.

A researcher sits at a desk and works at a computer in an office, viewed from behind computer monitors and office equipment. Large windows in the background overlook another building.

1 gene, 2 diseases: Sanders-Brown study reveals opposing dementia and cancer risks

Jul 1, 2026, 7:21 AM

Researchers at UK's Sanders-Brown Center on Aging have uncovered evidence that a single genetic variant may influence the risk of two of the diseases people fear most — dementia and cancer.

Two researchers wearing lab coats, safety glasses and protective gloves work together at a laboratory bench. One researcher uses a pipette to transfer a sample while the other observes and takes notes, surrounded by scientific equipment and sample trays.

Could nighttime light affect brain health? UK researchers investigate Alzheimer’s links

Jun 22, 2026, 7:34 AM

New research from UK's Sanders-Brown Center on Aging is shedding light on how everyday environmental factors and inflammation in the brain could influence sleep, circadian rhythms and Alzheimer’s-related changes.

Greg A. Gerhardt, Ph.D., a professor in the UK College of Medicine’s Department of Neuroscience and holds the Charles D. Lucas Jr. Professorship for Parkinson’s Disease Research, has been honored as a 2026-27 University Research Professor.

Greg Gerhardt: 2026-27 University Research Professor Q&A

Jun 11, 2026, 7:45 AM

UKNow is highlighting the University of Kentucky’s 2026-27 University Research Professors. Established by the Board of Trustees in 1976, the professorship program recognizes excellence across the full spectrum of research at UK and is sponsored by the Office of the Vice President for Research. 

CURE fellowship students

11 students awarded CURE Fellowships

May 14, 2026, 7:18 AM

UK's Office of Undergraduate Research has announced the 11 students selected for the 2026 Commonwealth Undergraduate Research Experience Fellowship program.

UK Sanders-Brown Center on Aging | Saddle Up for Brain Health

A legacy of learning: Sanders-Brown summit brings brain health expertise to the community

Apr 22, 2026, 7:35 AM

May 18, Sanders-Brown will host its 18th annual Mind Matters Health Summit, bringing cutting-edge research and expert guidance directly to the community.

an illustration of a brain in a head

UK contributes to global study showing where people live may impact how the brain ages

Apr 16, 2026, 8:00 AM

A recent study, including research from UK, shows that brain health is shaped not only by biology and individual choices, but also by the broader environments people live in

Lance Johnson and Josh Morganti

UK study finds blood clues to serious side effects of new Alzheimer’s drug

Mar 9, 2026, 7:10 AM

A UK study reveals a distinct immune “fingerprint” in the blood of patients who develop amyloid-related imaging abnormalities (ARIA) after Alzheimer's treatment with lecanemab.

Filter News

University of Kentucky Homepage A link to return to the University of Kentucky Homepage
An Equal Opportunity University
Accreditation
Directory
Email
Privacy Policy
Accessibility
Disclosures
© University of Kentucky
Lexington, Kentucky 40506